Af­ter re­fut­ing a sup­posed da­ta leak as 'fal­si­fied', Ole­ma re­veals first clin­i­cal da­ta for lead pro­gram — shares crash

Ole­ma On­col­o­gy had been prepar­ing to present the first clin­i­cal da­ta from its lead pro­gram at a con­fer­ence next week, but the biotech’s poster sup­pos­ed­ly leaked on­line Mon­day. In re­sponse, Ole­ma is­sued a state­ment say­ing the im­age was fal­si­fied, and pub­lished topline re­sults in a press re­lease Tues­day morn­ing.

The leaked poster os­ten­si­bly came from a pa­tient in the Phase I por­tion of the study, who post­ed on a dis­cus­sion fo­rum af­ter say­ing they com­plet­ed treat­ment and re­ceived a sum­ma­ry. Orig­i­nal­ly writ­ten on the ad­vo­ca­cy web­site In­spire.com, the fo­rum now leads to a 404 page, but some so­cial me­dia users man­aged to screen­shot the post.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER